Paper24939745
Advances in lipid-based colloid systems as drug carrier for topic delivery.
Zhai Y and 1 other. J Control Release, 2014. Cited by 115 papers, by iCite.
Cite this record
ConductScience Library. Advances in lipid-based colloid systems as drug carrier for topic delivery. Papers, record 24939745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24939745
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Carriers | Major topic |
| Lipids | Major topic |
| Nanoparticles | Major topic |
| Pharmaceutical Preparations | Major topic |
| Skin | Major topic |
| Administration, Cutaneous | |
| Animals | |
| Colloids | |
| Humans | |
| Skin Absorption |
Source PubMed
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41550144 | The effect of particle size on drug bioavailability in various parts of the body. | Pharm Sci Adv | 2024 | https://conductscience.org/library/papers/41550144 | PubMed |
| 40871007 | Advances in Transdermal Delivery Systems for Treating Androgenetic Alopecia. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40871007 | PubMed |
| 40860148 | Synergistic integration of extracellular vesicles and metal-organic frameworks: unlocking new opportunities in disease diagnosis and therapy. | Theranostics | 2025 | https://conductscience.org/library/papers/40860148 | PubMed |
| 39942745 | Potential of the Nano-Encapsulation of Antioxidant Molecules in Wound Healing Applications: An Innovative Strategy to Enhance the Bio-Profile. | Molecules | 2025 | https://conductscience.org/library/papers/39942745 | PubMed |
| 39428928 | Nanostructured Lipid Carrier-based Topical Gels as Novel Drug Delivery System: A Comprehensive Overview. | Curr Drug Deliv | 2025 | https://conductscience.org/library/papers/39428928 | PubMed |
| 39403134 | Hyaluronic acid-solid lipid nano transporter serum preparation for enhancing topical tretinoin delivery: skin safety study and visual assessment of skin. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39403134 | PubMed |
| 39082164 | Topical Administration of Nanostructured Lipid Carriers as a Viable Approach to Reduce Inflammation: A Review. | Antiinflamm Antiallergy Agents Med Chem | 2025 | https://conductscience.org/library/papers/39082164 | PubMed |
| 38585452 | Green Formulation of Spironolactone Loaded Chitosan-Coated Nano Lipid Carrier for Treatment of Acne Vulgaris: A Randomized Double-Blind Clinical Trial. | Adv Pharm Bull | 2024 | https://conductscience.org/library/papers/38585452 | PubMed |
| 36839978 | Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839978 | PubMed |
| 36826914 | Combinational System of Lipid-Based Nanocarriers and Biodegradable Polymers for Wound Healing: An Updated Review. | J Funct Biomater | 2023 | https://conductscience.org/library/papers/36826914 | PubMed |
| 36159679 | Enhanced efficiency of melatonin by stepwise-targeting strategy for acute lung injury. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36159679 | PubMed |
| 36042733 | Finasteride-loaded nano-lipidic carriers for follicular drug delivery: preformulation screening and Box-Behnken experimental design for optimization of variables. | Heliyon | 2022 | https://conductscience.org/library/papers/36042733 | PubMed |
| 35583641 | Dermal Delivery of Lipid Nanoparticles: Effects on Skin and Assessment of Absorption and Safety. | Adv Exp Med Biol | 2022 | https://conductscience.org/library/papers/35583641 | PubMed |
| 35566084 | A Review of Potential Use of Amazonian Oils in the Synthesis of Organogels for Cosmetic Application. | Molecules | 2022 | https://conductscience.org/library/papers/35566084 | PubMed |
| 35517758 | A novel biocompatible, simvastatin-loaded, bone-targeting lipid nanocarrier for treating osteoporosis more effectively. | RSC Adv | 2020 | https://conductscience.org/library/papers/35517758 | PubMed |
| 35423006 | Vesicular systems for dermal and transdermal drug delivery. | RSC Adv | 2020 | https://conductscience.org/library/papers/35423006 | PubMed |
| 35284985 | Effect of zeta potential of innovative lipid nanocapsules on triamcinolone transdermal delivery. | Drug Deliv Transl Res | 2022 | https://conductscience.org/library/papers/35284985 | PubMed |
| 34834124 | Nanoantioxidants: Pioneer Types, Advantages, Limitations, and Future Insights. | Molecules | 2021 | https://conductscience.org/library/papers/34834124 | PubMed |
| 34588846 | Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies. | Saudi Pharm J | 2021 | https://conductscience.org/library/papers/34588846 | PubMed |
| 34575531 | Nanostructured Lipid Carriers for the Formulation of Topical Anti-Inflammatory Nanomedicines Based on Natural Substances. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34575531 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24939745
GET https://conductscience.org/api/papers/v1/24939745/cited_by?page=2